Category: Herz-Kreislauf-Erkrankungen

Study: Coronary Heart Disease Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Singh RB; Wander GS; Rastogi A; Shukla PK; Mittal A; Sharma JP; Mehrotra SK; Kapoor R; Chopra RK Cardiovasc Drugs Ther 1998 Sep;12(4):347-53 The effects of oral treatment with coenzyme Q10 (120 mg/d) were compared for 28 days […] More

Study: Coronary Heart Disease Effect of homocysteine-lowering therapy with folic acid, vitamin B(12), and vitamin B(6) on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM Journal of the American Medical Association 2002 Aug 28;288(8):973-9 CONTEXT: Plasma homocysteine level has […] More

Study: Coronary Heart Disease Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Dalery K; Lussier-Cacan S; Selhub J; Davignon J; Latour Y; Genest J Am J Cardiol 1995 Jun 1;75(16):1107-11 We determined plasma levels of homocysteine in 584 healthy subjects (380 men and 204 women) […] More

Study: Coronary Heart Disease Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Regnstrom J; Nilsson J; Moldeus P; Strom K; Bavenholm P; Tornvall P; Hamsten A Am J Clin Nutr 1996 Mar;63(3):377-85 Oxidation of low-density lipoprotein (LDL) is believed to play an important role in atherogenesis, and antioxidant […] More

Study: Coronary Heart Disease Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Robinson K; Arheart K; Refsum H; Brattstrom L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I Circulation 1998 Feb 10;97(5):437-43 BACKGROUND: A […] More

Study: Coronary Heart Disease Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Davey PJ; Schulz M; Gliksman M; Dobson M; Aristides M; Stephens NG Am J Cardiol 1998 Aug 15;82(4):414-7 Epidemiologic studies have suggested that vitamin E (alpha-tocopherol) may play a preventive […] More

Study: Coronary Heart Disease Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Singh RB; Niaz MA; Sharma JP; Kumar R; Bishnoi I; Begom R Acta Cardiologica 1994;49(5):441-52 Of 138 patients with suspected acute myocardial infarction (AMI), 29 were excluded. Remaining 109 patients and 182 healthy controls of similar age […] More

Study: Coronary Heart Disease Vitamin E analogues reduce the incidence of ventricular fibrillations and scavenge free radicals. Walker MK; Vergely C; Lecour S; Abadie C; Maupoil V; Rochette L Fundam Clin Pharmacol 1998;12(2):164-72 The aim of our study was to analyse the protective effects of different alpha-tocopherol analogues 1) against fibrillations induced by an ischemia-reperfusion […] More

Study: Coronary Heart Disease Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias. Sebbag L; Forrat R; Canet E; Renaud S; Delaye J; de Lorgeril M Journal of the American College of Cardiology 1994 Nov 15;24(6):1580-5 OBJECTIVES. We investigated whether dietary supplementation with the antioxidant vitamin alpha-tocopherol (500 mg daily) might […] More

Study: Coronary Heart Disease Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Hu FB; Stampfer MJ; Manson JE; Rimm EB; Wolk A; Colditz GA; Hennekens CH; Willett WC American Journal of Clinical Nutrition 1999 May;69(5):890-7 BACKGROUND: Experimental studies in laboratory animals and humans suggest that alpha-linolenic acid (18:3n-3) may […] More